Telix Pharmaceuticals Ltd has released a press release.
Czech Republic Grants National Authorisation for TLX591 Kit
Filed with ASX ·
Watch Telix Pharmaceuticals' latest callTelix Pharmaceuticals (ASX:TLX) Q2 2026 Earnings Call · Replay · Aug 20Read the transcript of Telix Pharmaceuticals (ASX:TLX) Q2 2026 Earnings Call6ix hasn’t read this filing yet.
Telix Pharmaceuticals Limited on 6ix
Earlier from Telix Pharmaceuticals
- Appendix 4C and Activities Report for December 2020 Quarter
- New Drug Submission filed with Health Canada for TLX591-CDx
- IP Agreement with U Southampton for access to TRALA data
- Telix Completes Acquisition of TheraPharm GmbH
- FDA New Drug Application for TLX591-CDx Proceeds to Review
Later from Telix Pharmaceuticals
- Shareholder update - year ended 31 December 2020
- Appendix 4E - Results for announcement to the market
- S&P DJI Announces March 2021 Quarterly Rebalance
- TGA commences priority evaluation process for Illuccix
- Launch of International NOBLE Registry for SPECT Imaging
Follow Telix Pharmaceuticals into a list and get an email when it puts out news.
Follow Telix Pharmaceuticals